![]() Nexomics Biosciences Nexomics Biosciences is a contract research organization offering gene-to‑structure services to the biopharmaceutical community. | CytoMed Therapeutics CytoMed Therapeutics is a company that focuses on translating its technologies into gamma delta (γδ) T cell- and natural killer (NK) cell-based immunotherapeutics for the treatment of cancers. | ![]() Reglagene Reglagene is a company that discovers and develops noninvasive therapeutic solutions that regain control of genes exploited by cancer to keep patients responsive to treatment. | ![]() Amgen Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics. | ||
Founding Date | Founding Date 2007 | Founding Date 2000 | Founding Date 2018 | Founding Date 2016 | Founding Date 1980 |
Type | Type Private | Type Public | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Rocky Hill, US HQ Mansfield, US | Locations HQ | Locations Singapore, SG HQ Masai, MY | Locations Tucson, US HQ | Locations Thousand Oaks, US HQ Hydra, DZ Vicente López, AR Sydney, AU Wien, AT Diegem, BE Santo Amaro, BR see more |
Employees | Employees 1220% increase | Employees 563 | Employees 24 | Employees 14 | Employees 25,200 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ₩124.6b (FY, 2023) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $36.8b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods ₩104.4b (FY, 2023) | Cost of goods N/A | Cost of goods N/A | Cost of goods $12b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit ₩20.5b (FY, 2023) | Gross profit N/A | Gross profit N/A | Gross profit $24.7b (FY, 2025) |
Net income | Net income N/A | Net income (₩33.6b) (FY, 2023) | Net income N/A | Net income N/A | Net income $7.7b (FY, 2025) |
CytoMed Therapeutics is a company that focuses on translating its technologies into gamma delta (γδ) T cell- and natural killer (NK) cell-based immunotherapeutics for the treatment of cancers.
View company
Reglagene is a company that discovers and develops noninvasive therapeutic solutions that regain control of genes exploited by cancer to keep patients responsive to treatment.
View company
Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics.
View company